|Articles|March 10, 2022
SEC-MALS Method for Characterizing mRNA v2
Author(s)Wyatt Technology
SEC-MALS quantifies biophysical attributes of mRNA including molar mass, percent aggregates, Rg and Rh, and how they are affected by formulation and storage conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Novel Delivery Approaches of Biopharmaceuticals 2025
2
FAQ: What You Need to Know about the Current Antibody Pipeline
3
Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy
4
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
5